HSIF14 · House Subcommittee

Health Subcommittee

House Energy and Commerce Subcommittee on Health

Showing the 118th Congress (2023–2024). Back to the 119th Congress

1,296 bills referred in the 118th Congress

10,366 across the 13 Congresses on file, most in the 117th at 1,379. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 107th to 119th

Members
30

Served in the 118th Congress

Meetings
35

Hearings and business meetings in the 118th Congress

Members, 118th Congress 30

Everyone listed on the subcommittee in the 118th Congress, from printed hearings, the Congressional Directory and the official rosters.

Record

Bills, meetings, hearings, reports and more, newest first. In the 118th Congress.

Hearings, markups and business meetings, newest first. In the 118th Congress.

KindSubjectStatusDate
MeetingSupporting Access to Long-Term Services and Supports: An Examination of the Impacts of Proposed Regulations on Workforce and Access to CareRayburn House Office Building 2123
5 witnesses
  • Ms. Lori Smetanka, Executive Director, The National Consumer Voice for Quality Long-Term Care
  • Ms. Sarah Schumann, Vice President of Operations, Brookside Inn
  • Ms. Patti Killingsworth, Former Chief of LTSS, TennCare; Chief Strategy Officer, CareBridge Health
  • Ms. Mary Killough, Vice President of Operations and Government Relations, AccentCare
  • Ms. Shelly Hughes, Certified Nurse Aide
ScheduledOct 25, 2023
MeetingWhat's the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for DoctorsRayburn House Office Building 2123
7 witnesses
  • Dr. Meena Seshamani, MD, PhD, Director, Center for Medicare, Centers for Medicare & Medicaid Services (CMS)
  • Mr. Paul Masi, MPP, Executive Director, Medicare Payment Advisory Commission (MedPAC)
  • Dr. Steven Furr, MD, FAAFP, President-Elect, American Academy of Family Physicians
  • Dr. Debra Patt, MD, PhD, MBA, Executive Vice President, Texas Oncology
  • Mr. Joe Albanese, MPP, Senior Policy Analyst, Paragon Health Institute
  • Ms. Leslie Gordon, MPP, Director, Health Care, U.S. Government Accountability Office (GAO)
  • Dr. Matthew Fiedler, PhD, Joseph A. Pechman Senior Fellow in Economic Studies, Brookings Schaeffer Intitiative on Health Policy, The Brookings Institution
ScheduledOct 19, 2023
MeetingExamining Policies to Improve Seniors' Access to Innovative Drugs, Medical Devices, and TechnologyRayburn House Office Building 2322
2 witnesses
  • Mr. John Dicken, Director, Health Care - Public and Private Markets, U.S. Government Accountability Office
  • Dr. Dora Hughes, MD, MPH, Acting Director, Center for Clinical Standards and Quality, Acting Chief Medical Officer, U.S. Centers for Medicare and Medicaid Services
ScheduledSep 19, 2023
MeetingLegislative Proposals to Prevent and Respond to Generic Drug ShortagesRayburn House Office Building 2123
6 witnesses
  • Mr. Michael Ganio, Pharm.D., M.S., BCSCP, FASHP, Senior Director, Pharmacy Practice and Quality, American Society of Health System Pharmacists
  • Mr. Chester "Chip" Davis, Jr., JD, President and Chief Executive Officer, Healthcare Distribution Alliance
  • Dr. Melissa Barber, PhD, Postdoctoral fellow at the Yale School of Medicine, Yale Law School, and Yale Collaboration for Regulatory Rigor, Integrity, and Transparency
  • Mr. Allan Coukell, BScPharm, Senior Vice President, Public Policy, Civica
  • Mr. David Gaugh, Interim President and CEO, Association for Accessible Medicines
  • Mr. Todd Ebert, R.Ph., President and CEO, Healthcare Supply Chain Association
ScheduledSep 14, 2023
MeetingInnovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and TechnologyRayburn House Office Building 2322
6 witnesses
  • Ms. Sue Wronsky, Alzheimer's Association Advocate
  • Dr. Brian Miller, M.D., Nonresident Fellow, American Enterprise Institute, Assistant Professor of Medicine, Johns Hopkins University School of Medicine
  • Dr. Lishan Aklog, M.D., Chairman and Chief Executive Officer, PAVmed
  • Dr. Todd Brinton, M.D., Corporate Vice President, Advanced Technology Chief Scientific Officer, Edwards Lifesciences
  • Dr. Natalia Rost, M.D., President Elect, American Academy of Neurology
  • Dr. Thomas MacGillivray, M.D., President, Society of Thoracic Surgeons
ScheduledJul 18, 2023
MarkupMarkup of 17 Pieces of LegislationScheduledJul 13, 2023
MeetingResponding to America's Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT ActRayburn House Office Building 2322
5 witnesses
  • Dr. Christopher Jones, PharmD, DrPH, MPH, Director of the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention
  • Mr. Tom Coderre, Acting Deputy Assistant Secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration
  • Mr. Jonathan Blum, MPP, Principal Deputy Administrator and Chief Operating Officer, Centers for Medicare and Medicaid Services
  • Mr. Matthew Strait, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration
  • Ms. Diana Espinosa, MPP, Principal Deputy Administrator, Health Resources and Services Administration
ScheduledJun 21, 2023
MeetingExamining Proposals that Provide Access to Care for Patients and Support Research for Rare Diseases
6 witnesses
  • Mr. Kevin O'Connor, Assistant to the General President for Government Affairs and Political Action, International Association of Fire Fighters
  • Dr. Elizabeth Cherot, MD, MBA, Senior Vice President and Chief Medical Health Officer, March of Dimes
  • Dr. Alexis Thompson, MD, MPH, Chief of Division of Hematology, Elias Schwartz MD Endowed Chair in Hematology
  • Dr. Miriam Grossman, MD, Child, Adolescent, and Adult Psychiatrist
  • Mr. George Manahan, Parkinson's Advocate and Patient
  • Dr. Meredithe McNamara, MD, MS, FAAP, Assistant Professor, Yale School of Medicine
ScheduledJun 14, 2023

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

CongressMembersBills referredReportedBecame lawMeetings
119th2025–2026, sitting323535225
118th2023–2024301,296901335
117th2021–2022341,379391327
116th2019–202049795371036
115th2017–201834780491750
114th2015–201631773281436
113th2013–201431741131825
112th2011–2012286511360
111th2009–2010397462710—
110th2007–2008338922720—
109th2005–200632815922—
108th2003–200481746522—
107th2001–2002337171112—

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. A subcommittee's referrals are recorded against it separately from its parent's, so the two lists do not add up. Records come from Congress.gov, GovInfo and the House and Senate.